Cargando…
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel
Chimeric antigen receptor (CAR) T cell–related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a challenging diagnosis. The establishment of specific diagnosis criteria is essential, and the combination of several techniques for CAR T‐cell follow...
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741874/ https://www.ncbi.nlm.nih.gov/pubmed/35028140 http://dx.doi.org/10.1002/ccr3.5209 |
| _version_ | 1784629586219237376 |
|---|---|
| author | Martín‐Rojas, Reyes Maria Gómez‐Centurión, Ignacio Bailén, Rebeca Bastos, Mariana Diaz‐Crespo, Francisco Carbonell, Diego Correa‐Rocha, Rafael Pion, Marjorie Muñoz, Cristina Sancho, Milagros Gómez Fernández, Isabel Oarbeascoa, Gillen Pérez‐Corral, Ana Martínez‐Laperche, Carolina Anguita, Javier Buño, Ismael Menárguez, Javier Díez‐Martín, Jose Luis Kwon, Mi |
| author_facet | Martín‐Rojas, Reyes Maria Gómez‐Centurión, Ignacio Bailén, Rebeca Bastos, Mariana Diaz‐Crespo, Francisco Carbonell, Diego Correa‐Rocha, Rafael Pion, Marjorie Muñoz, Cristina Sancho, Milagros Gómez Fernández, Isabel Oarbeascoa, Gillen Pérez‐Corral, Ana Martínez‐Laperche, Carolina Anguita, Javier Buño, Ismael Menárguez, Javier Díez‐Martín, Jose Luis Kwon, Mi |
| author_sort | Martín‐Rojas, Reyes Maria |
| collection | PubMed |
| description | Chimeric antigen receptor (CAR) T cell–related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a challenging diagnosis. The establishment of specific diagnosis criteria is essential, and the combination of several techniques for CAR T‐cell follow‐up, allows a more precise management of this complication. |
| format | Online Article Text |
| id | pubmed-8741874 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87418742022-01-12 Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel Martín‐Rojas, Reyes Maria Gómez‐Centurión, Ignacio Bailén, Rebeca Bastos, Mariana Diaz‐Crespo, Francisco Carbonell, Diego Correa‐Rocha, Rafael Pion, Marjorie Muñoz, Cristina Sancho, Milagros Gómez Fernández, Isabel Oarbeascoa, Gillen Pérez‐Corral, Ana Martínez‐Laperche, Carolina Anguita, Javier Buño, Ismael Menárguez, Javier Díez‐Martín, Jose Luis Kwon, Mi Clin Case Rep Case Report Chimeric antigen receptor (CAR) T cell–related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a challenging diagnosis. The establishment of specific diagnosis criteria is essential, and the combination of several techniques for CAR T‐cell follow‐up, allows a more precise management of this complication. John Wiley and Sons Inc. 2022-01-07 /pmc/articles/PMC8741874/ /pubmed/35028140 http://dx.doi.org/10.1002/ccr3.5209 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Case Report Martín‐Rojas, Reyes Maria Gómez‐Centurión, Ignacio Bailén, Rebeca Bastos, Mariana Diaz‐Crespo, Francisco Carbonell, Diego Correa‐Rocha, Rafael Pion, Marjorie Muñoz, Cristina Sancho, Milagros Gómez Fernández, Isabel Oarbeascoa, Gillen Pérez‐Corral, Ana Martínez‐Laperche, Carolina Anguita, Javier Buño, Ismael Menárguez, Javier Díez‐Martín, Jose Luis Kwon, Mi Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel |
| title | Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel |
| title_full | Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel |
| title_fullStr | Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel |
| title_full_unstemmed | Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel |
| title_short | Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel |
| title_sort | hemophagocytic lymphohistiocytosis/macrophage activation syndrome (hlh/mas) following treatment with tisagenlecleucel |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741874/ https://www.ncbi.nlm.nih.gov/pubmed/35028140 http://dx.doi.org/10.1002/ccr3.5209 |
| work_keys_str_mv | AT martinrojasreyesmaria hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT gomezcenturionignacio hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT bailenrebeca hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT bastosmariana hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT diazcrespofrancisco hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT carbonelldiego hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT correarocharafael hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT pionmarjorie hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT munozcristina hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT sanchomilagros hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT gomezfernandezisabel hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT oarbeascoagillen hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT perezcorralana hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT martinezlaperchecarolina hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT anguitajavier hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT bunoismael hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT menarguezjavier hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT diezmartinjoseluis hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel AT kwonmi hemophagocyticlymphohistiocytosismacrophageactivationsyndromehlhmasfollowingtreatmentwithtisagenlecleucel |